Top Tweets for #ethanstudy
It's #MensBreastCancerAwarenessWeek and @DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- breast cancer prior to surgery for #MaleBreastCancer.
For more information call 877-338-7425 or visit:
https://t.co/zsYl0craF1
#MaleBreastCancerAwareness @MBCGlobAlliance
@DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- breast cancer prior to surgery #MaleBreastCancer.
For more information call 877-338-7425 or visit:
https://t.co/wmcrnUWvXR
@DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- #BreastCancer prior to surgery for #MaleBreastCancer.
For more information call 877-338-7425 or visit:
https://t.co/wmcrnUWvXR
@DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- #BreastCancer prior to surgery #MaleBreastCancer.
For more information call 877-338-7425 or visit:
https://t.co/zsYl0crIuz
PI: Dr. Jose Pablo Leone
@DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- breast cancer prior to surgery for #MaleBreastCancer.
For more information call 877-338-7425 or visit:
https://t.co/wmcrnUWvXR
The Breast Oncology Center and @TheTBCRC are leading the #ETHANstudy, a randomized study for men with stage I-III hormone receptor-positive (HR+)/HER2-negative #BreastCancer. This study is looking to see how well male breast cancer responds to pre-surgery treatment with endocrine therapy and which endocrine therapy drug is the most effective treatment for male breast cancer.
#MaleBreastCancer research is important because it is rare which means many men don’t know about it and it is often caught late. This research will be key to advancing our understanding of this disease, and to developing the best therapies possible.
For more information call 877-DF-TRIAL (877-338-7425) or visit: dana -farber.org/clinical-trials/22-225
#Malebreastcancerawarenessweek #Malebreastcancerawarenes #JosePabloLeone #Breastcancerawarenessweek @MBCGlobAlliance
@DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- #BreastCancer prior to surgery #MaleBreastCancer.
For more information call 877-338-7425 or visit:
https://t.co/wmcrnUWvXR
The Breast Oncology Center is leading the #ETHANstudy, a randomized study for men with stage I-III hormone receptor-positive (HR+)/HER2-negative #BreastCancer. This research study is looking to see how well #MaleBreastCancer responds to pre-surgery treatment with endocrine therapy and which endocrine therapy drug is the most effective treatment for male breast cancer. For more information call 877-338-7425 or visit:
https://t.co/zsYl0craF1
@DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- breast cancer prior to surgery. #MaleBreastCancer
For more information call 877-338-7425 or visit:
https://t.co/wmcrnUWvXR
@DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- breast cancer prior to surgery #MaleBreastCancer.
For more info call 877-338-7425 or visit:
https://t.co/wmcrnUX3Np @MBCGAlliance
We finally have a clinical trial designed specifically for men with breast cancer. @MayoCancerCare and @TheTBCRC have launched TBCRC059, the #ETHANstudy, a study that may revolutionize pre-operative treatment. For more information, please call 855-776-0015 and reference TBCRC059.
@DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- breast cancer prior to surgery #MaleBreastCancer
For more information call 877-338-7425 or visit:
https://t.co/zsYl0craF1 PI: Dr. Jose Pablo Leone
@DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- #BreastCancer prior to surgery.
For more information call 877-338-7425 or visit:
https://t.co/wmcrnUWvXR #MaleBreastCancer
We finally have a clinical trial designed specifically for men with breast cancer. @MayoCancerCare and @TheTBCRC have launched TBCRC059, the #ETHANstudy, a study that may revolutionize pre-operative treatment. For more information, please call 855-776-0015 and reference TBCRC059.
@DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- breast cancer prior to surgery #MaleBreastCancer.
For more information call 877-338-7425 or visit:
https://t.co/wmcrnUX3Np
@DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- breast cancer prior to surgery #MaleBreastCancer
For more information call 877-338-7425 or visit:
https://t.co/wmcrnUX3Np
@DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- #BreastCancer prior to surgery for #MaleBreastCancer.
For more information call 877-338-7425 or visit:
https://t.co/wmcrnUX3Np
Every voice matters on #RareDiseaseDay. Let's shine a light on male breast cancer, a rare and often overlooked condition. Let's unite, advocate and support much needed research, like the #ETHANstudy, to better understand #MaleBreastCancer.
On #RareDiseaseDay, let's highlight male breast cancer and ongoing efforts like the #ETHANstudy. Let's support research, spread awareness, and strive for better treatments for #MaleBreastCancer.
@DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- breast cancer prior to surgery #MaleBreastCancer.
For more information call 877-338-7425 or visit:
https://t.co/wmcrnUX3Np
@DFCI_BreastOnc and @TheTBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- breast cancer prior to surgery #MaleBreastCancer.
For more information call 877-338-7425 or visit:
https://t.co/wmcrnUX3Np
Last Seen Hashtags on Sotwe
brosis()****** filter:videos
Seen from United States
bursatravesti
Seen from Turkey
四爱
Seen from United States
CumInMeDaddy
Seen from Argentina
blueytheplantlizard
Seen from Poland
تانجو_برايفت
Seen from Germany
pornmommy
Seen from India
anxiouspanda(***)***+filter:native_video
Seen from Mexico
sister and brother
Seen from Pakistan
hijabnsfw
Seen from India
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers